Back
Revelation Biosciences Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
15
REVB
Revelation Biosciences
Last Price:
$2.42
Seasonality Move:
-23.49%
7 Day Trial
ALL ACCESS PASS
$
7

Invest Where Innovation Meets Real Demand
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Revelation Biosciences Stock Forecast
-
Is Revelation Biosciences Stock Undervalued?The current Revelation Biosciences [REVB] share price is $2.59. The Score for REVB is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
REVB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Revelation Biosciences Stock Go Up Next Year?
Data Unavailable
Revelation Biosciences Stock Rating
Data Unavailable
Revelation Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
revbiosciences.com
52-Week Data
52-Week High:
60.80
52-Week Low:
2.36
Prediction Charts
Market Cap:
2.5M
Price in USD:
2.59
Volume:
24.7K
Beta:
0.17
Technical Analysis
SMA50:
2.97
SMA100:
4.09
SMA200:
8.56
52-Wk Change:
-92.03%
Stock Predictions
-
Is Revelation Biosciences stock public?Yes, Revelation Biosciences is a publicly traded company.
-
What is the Revelation Biosciences stock quote today?The Revelation Biosciences stock price is 2.59 USD today.
-
How to buy Revelation Biosciences stock online?You can buy Revelation Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-5 | 3.05 | 2.90 | 3.09 | 2.85 |
May-6 | 2.95 | 2.90 | 3.00 | 2.86 |
May-7 | 2.90 | 2.90 | 3.07 | 2.90 |
May-8 | 2.96 | 3.10 | 3.10 | 2.87 |
May-9 | 3.04 | 3.18 | 3.21 | 3.04 |
May-12 | 3.22 | 3.26 | 3.34 | 3.13 |
May-13 | 3.30 | 3.18 | 3.30 | 3.13 |
May-14 | 3.24 | 3.13 | 3.32 | 3.13 |
May-15 | 3.13 | 3.03 | 3.13 | 3.03 |
May-16 | 3.03 | 3.05 | 3.30 | 3.00 |
May-19 | 3.02 | 3.14 | 3.25 | 3.02 |
May-20 | 3.12 | 2.51 | 3.27 | 2.44 |
May-21 | 2.52 | 2.57 | 2.69 | 2.52 |
May-22 | 2.55 | 2.59 | 2.67 | 2.55 |
Revelation Biosciences Earnings
Data Unavailable
Revelation Biosciences Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $43.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $111.59 per share, and an increase next year of $5.19 per share.
* Revelation Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.